CLINICAL_TRIALS
trial_result
· 2010-09-28
Clinical Trial Update: A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD) [Phase 2]
Summary
A Phase 2 clinical trial of KPS-0373 for spinocerebellar degeneration has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Spinocerebellar Degeneration | Phase 2 | Status: COMPLETED